Vault-13

Venrock Adviser, LLC

NEW YORK, NY · CIK 1615982 · 13F filing filed 2024-02-14

SEC-registered investment adviser since 2014 · limited liability company

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
New York, NY (main office)United States United Statesabout 11
Palo Alto, CAUnited States United States

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.5bn reported value +53.5% vs Q3 2023
36positions
68.3%in top 10
8 new 13 added 7 reduced 9 sold out vs Q3 2023

Holdings, Q4 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 RAYZEBIO INC COM COM 4,030,471 $250.6m17.19% 17.19% AddedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 4.0m, Q4 2023 4.0m +13.6k +13,624 0.3%
2 APOGEE THERAPEUTICS INC COM COM 8,493,321 $237.3m16.28% 16.28% UnchangedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 8.5m, Q4 2023 8.5m
3 PHARVARIS N V COM PHVS PHVS 3,395,606 $95.2m6.53% 6.53% AddedShares held: Q1 2023 0, Q2 2023 1.3m, Q3 2023 1.6m, Q4 2023 3.4m +1.8m +1,832,093 117.2%
4 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 3,882,623 $84.6m5.80% 5.80% AddedShares held: Q1 2023 2.7m, Q2 2023 3.1m, Q3 2023 3.1m, Q4 2023 3.9m +800.0k +800,001 25.9%
5 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 3,424,031 $69.4m4.76% 4.76% AddedShares held: Q1 2023 0, Q2 2023 3.0m, Q3 2023 3.0m, Q4 2023 3.4m +424.0k +424,031 14.1%
6 MERUS N V COM MRUS MRUS 2,148,214 $59.1m4.05% 4.05% AddedShares held: Q1 2023 1.2m, Q2 2023 1.7m, Q3 2023 1.7m, Q4 2023 2.1m +422.0k +422,000 24.4%
7 CABALETTA BIO INC COM CABA CABA 2,563,952 $58.2m3.99% 3.99% AddedShares held: Q1 2023 2.0m, Q2 2023 2.0m, Q3 2023 2.0m, Q4 2023 2.6m +590.7k +590,699 29.9%
8 SPYRE THERAPEUTICS INC COM NEW SYRE SYRE 2,372,714 $51.1m3.50% 3.50% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 2.4m
9 KALVISTA PHARMACEUTICALS INC COM KALV KALV 4,092,731 $50.1m3.44% 3.44% AddedShares held: Q1 2023 2.9m, Q2 2023 2.9m, Q3 2023 2.9m, Q4 2023 4.1m +1.2m +1,176,064 40.3%
10 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 2,954,902 $40.9m2.80% 2.80% UnchangedShares held: Q1 2023 2.2m, Q2 2023 2.2m, Q3 2023 3.0m, Q4 2023 3.0m
11 OCULAR THERAPEUTIX INC COM OCUL OCUL 7,775,760 $34.7m2.38% 2.38% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 7.8m
12 HILLEVAX INC COM COM 2,075,000 $33.3m2.28% 2.28% AddedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 2.0m, Q4 2023 2.1m +37.7k +37,687 1.9%
13 AMBRX BIOPHARMA INC COM COM 2,070,000 $29.5m2.02% 2.02% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 2.1m
14 TERNS PHARMACEUTICALS INC COM COM 4,497,117 $29.2m2.00% 2.00% AddedShares held: Q1 2023 3.6m, Q2 2023 3.0m, Q3 2023 3.1m, Q4 2023 4.5m +1.4m +1,404,844 45.4%
15 DYNE THERAPEUTICS INC COM DYN DYN 2,173,913 $28.9m1.98% 1.98% UnchangedShares held: Q1 2023 0, Q2 2023 2.2m, Q3 2023 2.2m, Q4 2023 2.2m
16 COGENT BIOSCIENCES INC COM COGT COGT 4,684,167 $27.5m1.89% 1.89% UnchangedShares held: Q1 2023 4.9m, Q2 2023 4.7m, Q3 2023 4.7m, Q4 2023 4.7m
17 CELCUITY INC COM CELC CELC 1,885,538 $27.5m1.88% 1.88% ReducedShares held: Q1 2023 2.1m, Q2 2023 2.1m, Q3 2023 2.1m, Q4 2023 1.9m -219.8k -219,848 -10.4%
18 MERSANA THERAPEUTICS INC COM COM 11,328,000 $26.3m1.80% 1.80% UnchangedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 11.3m, Q4 2023 11.3m
19 ARVINAS INC COM ARVN ARVN 627,788 $25.8m1.77% 1.77% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 627.8k
20 ASTRIA THERAPEUTICS INC COM CATB CATB 3,225,806 $24.8m1.70% 1.70% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 3.2m
21 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 495,983 $22.8m1.56% 1.56% ReducedShares held: Q1 2023 0, Q2 2023 1.1m, Q3 2023 1.1m, Q4 2023 496.0k -594.0k -594,017 -54.5%
22 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,428,385 $22.3m1.53% 1.53% AddedShares held: Q1 2023 0, Q2 2023 2.1m, Q3 2023 2.1m, Q4 2023 2.4m +285.5k +285,529 13.3%
23 APPLIED THERAPEUTICS INC COM APLT APLT 6,250,000 $20.9m1.44% 1.44% AddedShares held: Q1 2023 0, Q2 2023 5.7m, Q3 2023 5.7m, Q4 2023 6.2m +592.0k +591,966 10.5%
24 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 10,412,872 $18.4m1.26% 1.26% ReducedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 14.4m, Q4 2023 10.4m -4.0m -4,031,572 -27.9%
25 SAVARA INC COM SVRA SVRA 3,500,000 $16.4m1.13% 1.13% ReducedShares held: Q1 2023 6.4m, Q2 2023 6.4m, Q3 2023 7.2m, Q4 2023 3.5m -3.7m -3,684,865 -51.3%
26 LYRA THERAPEUTICS INC COM LYRA LYRA 2,575,593 $13.5m0.93% 0.93% AddedShares held: Q1 2023 924.2k, Q2 2023 924.2k, Q3 2023 924.2k, Q4 2023 2.6m +1.7m +1,651,423 178.7%
27 ABIVAX SA SPONSORED ADS ABVX ABVX 998,570 $10.7m0.73% 0.73% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 998.6k
28 DIANTHUS THERAPEUTICS INC COM DNTH DNTH 927,706 $9.6m0.66% 0.66% UnchangedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 927.7k, Q4 2023 927.7k
29 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 353,626 $7.9m0.54% 0.54% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 353.6k
30 GH RESEARCH PLC ORDINARY SHARES GHRS GHRS 1,318,327 $7.6m0.52% 0.52% ReducedShares held: Q1 2023 3.5m, Q2 2023 3.5m, Q3 2023 2.7m, Q4 2023 1.3m -1.4m -1,425,798 -52.0%
31 ACELYRIN INC COM COM 937,113 $7.0m0.48% 0.48% AddedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 864.3k, Q4 2023 937.1k +72.8k +72,781 8.4%
32 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 250,000 $5.8m0.40% 0.40% NewShares held: Q1 2023 0, Q2 2023 0, Q3 2023 0, Q4 2023 250.0k
33 TREVI THERAPEUTICS INC COM TRVI TRVI 3,422,397 $4.6m0.31% 0.31% UnchangedShares held: Q1 2023 3.1m, Q2 2023 3.4m, Q3 2023 3.4m, Q4 2023 3.4m
34 ADVERUM BIOTECHNOLOGIES INC COM COM 5,147,547 $3.9m0.27% 0.27% ReducedShares held: Q1 2023 0, Q2 2023 3.9m, Q3 2023 6.6m, Q4 2023 5.1m -1.4m -1,425,753 -21.7%
35 MILESTONE PHARMACEUTICALS IN COM MIST MIST 925,048 $1.5m0.11% 0.11% ReducedShares held: Q1 2023 2.2m, Q2 2023 2.2m, Q3 2023 2.2m, Q4 2023 925.0k -1.3m -1,283,764 -58.1%
36 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 77,042 $1.1m0.07% 0.07% UnchangedShares held: Q1 2023 0, Q2 2023 0, Q3 2023 77.0k, Q4 2023 77.0k

Sold out since Q3 2023

SecurityTickerShares held beforeValue then
AMBRX BIOPHARMA INC 2,070,000 $23.8m2.1m shares
TRAVERE THERAPEUTICS INC TVTX TVTX 2,623,677 $23.5m2.6m shares
PRAXIS PRECISION MEDICINES I 5,304,410 $9.1m5.3m shares
ACLARIS THERAPEUTICS INC ACRS ACRS 1,040,754 $7.1m1.0m shares
PLIANT THERAPEUTICS INC PLRX PLRX 288,949 $5.0m288.9k shares
SAGIMET BIOSCIENCES INC SGMT SGMT 515,000 $4.5m515.0k shares
AEGLEA BIOTHERAPEUTICS INC AGLE AGLE 295,034 $3.6m295.0k shares
RALLYBIO CORP 268,532 $905.0k268.5k shares
AFFIMED N V 1,428,571 $682.7k1.4m shares